GO:0004712 protein serine/threonine/tyrosine kinase activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0004712 describes dual-specificity protein kinase activity that phosphorylates serine, threonine, and tyrosine residues on protein substrates.
This activity is defined by the catalytic transfer of phosphate from ATP to three different amino acid acceptors, distinguishing it from strictly serine/threonine or tyrosine kinases.
STY kinases are found across kingdoms, from plants and cyanobacteria to mammals, and regulate diverse processes including antiviral defense, lipid metabolism, and carcinogenesis.
Dysregulation of dual-specificity kinases such as STYK1 contributes to pancreatic cancer through Wnt/β-catenin pathway hyperactivation.
The STYX pseudophosphatase domain illustrates how catalytically inactive relatives of dual-specificity kinases can act as dominant-negative regulators.
CRISPR knockout, point-mutation, and knock-in models are essential for dissecting the causal roles of specific serine, threonine, or tyrosine residues in kinase function.

Description

Protein serine/threonine/tyrosine kinase activity (GO:0004712) is a molecular function that catalyzes the phosphorylation of serine, threonine, and tyrosine residues on protein substrates using ATP as the phosphate donor. This dual-specificity activity is distinguished from conventional protein kinases that target only one class of hydroxyl amino acid, and it enables a single enzyme to modulate multiple signaling nodes. The term encompasses enzymes historically called dual-specificity kinases, which are critical for signal transduction in organisms ranging from cyanobacteria to humans. The biological importance of GO:0004712 is underscored by its roles in antiviral defense in plants, where STY46 phosphorylates the γb protein of hordeiviruses to restrict infection, and in lipid metabolism, where a serine/threonine/tyrosine kinase phosphorylates oleosin to regulate lipid storage. In mammals, dual-specificity kinases such as STYK1 drive pancreatic carcinogenesis by sequestering GSK3β and hyperactivating the Wnt/β-catenin pathway. Additionally, viral oncoproteins such as pp60src can exhibit serine/threonine-specific kinase activity, linking this function to oncogenic transformation. For researchers, GO:0004712 represents a convergence point for cell signaling, disease mechanisms, and therapeutic targeting. Understanding which residues are phosphorylated, which substrates are engaged, and how activity is regulated requires precise genetic and biochemical tools. This article synthesizes the current knowledge of dual-specificity kinase biology, its disease relevance, and the experimental models used to study it.

protein serine/threonine/tyrosine kinase activity At A Glance

GO ID GO:0004712
GO term protein serine/threonine/tyrosine kinase activity
Ontology molecular_function
Synonym dual-specificity kinase activity; dual-specificity protein kinase; protein threonine/tyrosine kinase activity
Major function Catalyzes ATP-dependent phosphorylation of serine, threonine, and tyrosine residues on protein substrates
Reaction ATP + protein serine/threonine/tyrosine = ADP + protein serine/threonine/tyrosine phosphate
Cofactor Magnesium or manganese ions typically required for ATP binding and catalysis
Substrate specificity Dual specificity for serine, threonine, and tyrosine residues
Related activity Protein kinase activity; phosphotransferase activity, alcohol group as acceptor

What Is GO:0004712?

GO:0004712, protein serine/threonine/tyrosine kinase activity, is defined as the catalysis of three reactions: ATP + a protein serine = ADP + protein serine phosphate; ATP + a protein threonine = ADP + protein threonine phosphate; and ATP + a protein tyrosine = ADP + protein tyrosine phosphate. In other words, it is a dual-specificity kinase activity that can phosphorylate all three hydroxyl-containing amino acids on protein substrates, using ATP as the phosphate donor.

Why Is protein serine/threonine/tyrosine kinase activity Important in Cell Biology?

GO:0004712 is important because dual-specificity kinases sit at the nexus of multiple signaling pathways, enabling a single enzyme to integrate serine, threonine, and tyrosine phosphorylation events that control cell growth, differentiation, immune responses, and metabolism. Their dysfunction is linked to cancer, hematological disorders, and viral pathogenesis, making them attractive targets for therapeutic intervention and biomarkers.
Dual-specificity kinases regulate antiviral defense in plants by phosphorylating viral proteins such as γb.
STYK1 drives pancreatic carcinogenesis through GSK3β sequestration and Wnt/β-catenin hyperactivation.
Serine/threonine/tyrosine kinases control lipid metabolism by phosphorylating oleosin in plants.
Protein kinases, including dual-specificity kinases, are implicated in hematological disorders and are drug targets.
Viral oncoproteins such as pp60src can exhibit serine/threonine kinase activity, linking this function to transformation.
The STYX pseudophosphatase domain provides a regulatory mechanism by competing with active kinases.
Cyanobacterial serine-threonine kinases illustrate evolutionary conservation of these signaling modules.
Serine residues are critical for the activity of plant dual-specificity kinases, highlighting substrate-dependent regulation.

What Happens During protein serine/threonine/tyrosine kinase activity?

Substrate recognition and binding
In simple terms: The kinase first grabs the target protein and positions it correctly.
Dual-specificity kinases recognize their substrates through specific docking interactions and consensus sequences surrounding the target serine, threonine, or tyrosine residue. For example, STY46 from plants specifically phosphorylates the γb protein of hordeiviruses, indicating precise substrate recognition. In Arabidopsis, a serine/threonine/tyrosine kinase depends on serine residues for its activity, suggesting that autophosphorylation or substrate serine recognition is critical.
ATP binding and phosphate transfer
In simple terms: The kinase uses ATP as an energy source to attach a phosphate group onto the target protein.
Upon substrate binding, the kinase binds ATP in its catalytic cleft, typically coordinated by magnesium ions. The γ-phosphate of ATP is then transferred to the hydroxyl group of the acceptor serine, threonine, or tyrosine residue, resulting in ADP and a phosphorylated protein. This reaction is the defining catalytic event of GO:0004712 and can occur on all three residue types, as demonstrated by a plant kinase that phosphorylates oleosin.
Dual-specificity phosphorylation
In simple terms: Unlike most kinases, this enzyme can tag three different amino acids, giving it broad control.
The hallmark of GO:0004712 is the ability to phosphorylate serine, threonine, and tyrosine residues. This was shown for a serine/threonine/tyrosine protein kinase from Arabidopsis thaliana that phosphorylates oleosin, a regulator of lipid metabolic functions. Similarly, STY46 exhibits dual-specificity activity against viral and plant substrates. This broad specificity allows a single kinase to modulate multiple signaling nodes simultaneously.
Regulation by autophosphorylation and pseudophosphatases
In simple terms: The kinase can turn itself on or off, and decoy proteins can block its action.
Many dual-specificity kinases undergo autophosphorylation to regulate their own activity. Additionally, pseudophosphatases such as STYX can bind substrates or partners without catalytic activity, acting as dominant-negative regulators of dual-specificity kinase signaling. This layer of regulation ensures that phosphorylation events are tightly controlled in time and space.
Downstream signaling and cellular outcomes
In simple terms: Once the target is phosphorylated, it can change cell behavior, such as growth or defense.
Phosphorylation by dual-specificity kinases alters substrate function, leading to diverse outcomes. In pancreatic cancer, STYK1 sequesters GSK3β, leading to Wnt/β-catenin pathway hyperactivation and enhanced carcinogenesis. In plants, STY46-mediated phosphorylation of γb restricts hordeivirus infection. In lipid metabolism, oleosin phosphorylation regulates lipid storage. These examples illustrate how GO:0004712 translates into physiological and pathological effects.

Key Genes Involved in GO:0004712 protein serine/threonine/tyrosine kinase activity

The following genes and proteins represent key examples of dual-specificity kinases or related factors that exhibit serine/threonine/tyrosine kinase activity or regulate it.
GeneMajor RoleResearch Relevance
STY46Phosphorylates γb protein to defend against hordeivirusPlant antiviral immunity model
STYK1Drives pancreatic carcinogenesis via GSK3β sequestration and Wnt/β-catenin activationOncogenic dual-specificity kinase target
Cyanobacterial STKsSerine-threonine kinases in cyanobacteriaEvolutionary and structural studies
Oleosin kinasePhosphorylates oleosin to regulate lipid metabolismPlant lipid storage and metabolic engineering
STYXPseudophosphatase that regulates dual-specificity kinase signalingDominant-negative regulator and signaling decoy
pp60srcViral oncoprotein with serine/threonine kinase activityOncogenic transformation and kinase cross-talk
Arabidopsis STY kinaseSerine-dependent dual-specificity kinasePlant kinase mechanism and substrate specificity
GSK3βSubstrate or sequestering partner of STYK1Wnt/β-catenin pathway regulation
γb proteinViral substrate of STY46Plant-virus interaction
OleosinPlant lipid droplet protein phosphorylated by dual-specificity kinaseLipid metabolism
Hematological kinase targetsProtein kinases involved in blood disordersTherapeutic targeting in leukemia/lymphoma
Cyanobacterial kinase regulatorsSerine-threonine kinase signaling componentsBacterial signal transduction

How Is protein serine/threonine/tyrosine kinase activity Regulated?

The activity of protein serine/threonine/tyrosine kinases is regulated at multiple levels. Autophosphorylation of serine residues is required for the activity of some plant dual-specificity kinases. Pseudophosphatases such as STYX can bind to and inhibit or sequester active kinases, providing a dominant-negative regulatory mechanism. In cancer, STYK1 sequesters GSK3β, leading to hyperactivation of Wnt/β-catenin signaling, illustrating how protein-protein interactions regulate downstream effects. Additionally, viral proteins such as pp60src can exhibit serine/threonine kinase activity, suggesting that viral infection can modulate host kinase networks.

protein serine/threonine/tyrosine kinase activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
STYK1Pancreatic cancerKnockout and overexpression in pancreatic cancer cell lines
STY46Hordeivirus infection in plantsPlant knockout and complementation
pp60srcViral oncogenesisPoint mutation of kinase domain in transformed cells
STYXSignaling dysregulationKnock-in of catalytically dead STYX
Oleosin kinaseLipid metabolism disordersOverexpression in plant or mammalian lipid models
Pancreatic cancer
STYK1, a serine/threonine/tyrosine kinase, drives pancreatic carcinogenesis by sequestering GSK3β and hyperactivating the Wnt/β-catenin pathway. This identifies STYK1 as a potential therapeutic target and biomarker in pancreatic cancer.
Hematological disorders
Protein kinases, including dual-specificity kinases, are frequently dysregulated in hematological malignancies such as leukemias and lymphomas, making them important targets for small-molecule inhibitors.
Viral pathogenesis and oncogenesis
The viral oncoprotein pp60src exhibits serine/threonine-specific kinase activity, linking dual-specificity phosphorylation to viral transformation. In plants, STY46-mediated phosphorylation of the γb protein restricts hordeivirus infection, demonstrating antiviral roles.
Metabolic and lipid disorders
A plant serine/threonine/tyrosine kinase phosphorylates oleosin, a regulator of lipid metabolic functions, suggesting that dual-specificity kinases may influence lipid storage and metabolic diseases.

From protein serine/threonine/tyrosine kinase activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of STYK1 reduce pancreatic tumor growth?STYK1 knockout in pancreatic cancer cell lines and xenografts
Which serine residues are required for kinase activity?Point mutations of serine to alanine in Arabidopsis STY kinase
Can STY46 phosphorylation of γb be blocked?Knock-in of phospho-deficient γb in plant models
Does STYX act as a dominant-negative regulator?Overexpression of catalytically inactive STYX
Is pp60src serine/threonine kinase activity required for transformation?Point mutation of catalytic residues in viral pp60src
How does oleosin phosphorylation affect lipid storage?Knockout or overexpression of oleosin kinase in plants

How to Study the protein serine/threonine/tyrosine kinase activity Process

MethodWhat It MeasuresTypical Application
In vitro kinase assayPhosphotransferase activity toward serine, threonine, tyrosineConfirming dual-specificity and testing inhibitors
PhosphoproteomicsGlobal phosphorylation sites on substratesMapping signaling networks
CRISPR knockoutLoss-of-function phenotypesValidating gene function in disease models
CRISPR knock-inEffect of specific point mutationsDissecting catalytic residues and phosphosites
OverexpressionGain-of-function effectsTesting oncogenic potential
Western blottingPhosphorylation status of specific proteinsValidating kinase activity in cells
Co-immunoprecipitationProtein-protein interactionsIdentifying substrates and regulators
Structural biology3D structure of kinase-substrate complexesRational drug design
Kinase activity assays
In vitro kinase assays using recombinant enzymes and substrate proteins can measure the transfer of radiolabeled or fluorescent phosphate from ATP to serine, threonine, or tyrosine residues. These assays are essential for confirming dual-specificity activity and for testing inhibitors.
Phosphoproteomics
Mass spectrometry-based phosphoproteomics can identify specific serine, threonine, and tyrosine phosphorylation sites on substrates of dual-specificity kinases, providing a global view of signaling networks.
Genetic knockout and knock-in models
CRISPR-Cas9 knockout of kinase genes, or knock-in of point mutations that abolish catalytic activity or phosphorylation sites, allows researchers to dissect the causal roles of GO:0004712 in cells and organisms.
Structural and biochemical studies
X-ray crystallography, cryo-EM, and biochemical assays can reveal how dual-specificity kinases bind ATP and recognize serine, threonine, and tyrosine substrates, informing drug design.

How CRISPR Can Be Used to Study GO:0004712 protein serine/threonine/tyrosine kinase activity

Knockout

CRISPR knockout of dual-specificity kinase genes such as STYK1 or STY46 can reveal their essential roles in cancer cell proliferation or plant antiviral defense. Knockout models are also used to identify compensatory pathways and to validate drug targets.

Point Mutation

Point mutations that substitute catalytic residues or key serine/threonine/tyrosine acceptors can abolish kinase activity or substrate phosphorylation. For example, mutating serine residues in Arabidopsis STY kinase reduces its activity, demonstrating their importance. Similar approaches can test the oncogenic requirement for STYK1 catalytic activity.

Knock-in

Knock-in of phospho-deficient or phospho-mimetic variants of substrate proteins, such as γb or oleosin, allows precise interrogation of phosphorylation-dependent functions in vivo. Tagged knock-in of kinases with fluorescent or affinity tags facilitates localization and interactome studies.

Overexpression

Overexpression of wild-type or mutant dual-specificity kinases can drive gain-of-function phenotypes, such as Wnt/β-catenin hyperactivation by STYK1 or dominant-negative regulation by STYX. Overexpression models are useful for testing oncogenicity and signaling cross-talk.

How EDITGENE Supports protein serine/threonine/tyrosine kinase activity Research

Researchers studying protein serine/threonine/tyrosine kinase activity-related genes often need to determine whether a candidate gene is causally involved in a specific pathway or disease. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for protein serine/threonine/tyrosine kinase activity research.

Frequently Asked Questions About protein serine/threonine/tyrosine kinase activity

It is a molecular function (GO:0004712) where an enzyme catalyzes the phosphorylation of serine, threonine, and tyrosine residues on protein substrates using ATP.
Examples include STY46 in plants, STYK1 in humans, and various cyanobacterial serine-threonine kinases.
Unlike typical kinases that target only serine/threonine or tyrosine, GO:0004712 enzymes can phosphorylate all three residues, giving them dual specificity.
They are linked to pancreatic cancer, hematological disorders, and viral pathogenesis.
Common methods include in vitro kinase assays, phosphoproteomics, and CRISPR knockout or knock-in models.
STYK1 drives pancreatic carcinogenesis by sequestering GSK3β and hyperactivating the Wnt/β-catenin pathway.
Yes, kinase inhibitors are being developed for hematological disorders and solid tumors, though specificity remains a challenge.
STYX acts as a dominant-negative regulator of dual-specificity kinase signaling by binding substrates without catalysis.
Phosphorylation of oleosin by a serine/threonine/tyrosine kinase regulates lipid storage and metabolic functions in plants.
Plant models such as Arabidopsis, mammalian cancer cell lines, and cyanobacteria are commonly used.

Conclusion

Protein serine/threonine/tyrosine kinase activity (GO:0004712) represents a critical dual-specificity enzymatic function that bridges multiple signaling pathways across kingdoms. Its roles in antiviral defense, lipid metabolism, and cancer highlight its biological and clinical importance. Understanding the mechanisms, substrates, and regulation of these kinases requires integrated genetic, biochemical, and computational approaches. EDITGENE offers a full suite of CRISPR services to accelerate discovery in this field.

References

  1. 1. Zhang X et al.. 2021. The serine/threonine/tyrosine kinase STY46 defends against hordeivirus infection by phosphorylating γb protein.. Plant Physiol 186(1):715-730 PMID: 33576790
  2. 2. Zhou C et al.. 2025. Serine/threonine/tyrosine kinase 1 drives pancreatic carcinogenesis via GSK3β sequestration-mediated Wnt/β-catenin pathway hyperactivation.. Signal Transduct Target Ther 10(1):205 PMID: 40588478
  3. 3. Zorina AA et al.. 2025. Serine-Threonine Protein Kinases of Cyanobacteria.. Biochemistry (Mosc) 90(Suppl 1):S287-S311 PMID: 40164163
  4. 4. Parthibane V et al.. 2012. Serine/threonine/tyrosine protein kinase phosphorylates oleosin, a regulator of lipid metabolic functions.. Plant Physiol 159(1):95-104 PMID: 22434039
  5. 5. Okay M et al.. 2021. Protein Kinases in Hematological Disorders.. Adv Exp Med Biol 1275:383-393 PMID: 33539024
  6. 6. Reddy MM et al.. 2007. Serine/threonine/tyrosine protein kinase from Arabidopsis thaliana is dependent on serine residues for its activity.. Arch Biochem Biophys 460(1):122-8 PMID: 17291444
  7. 7. Reiterer V et al.. 2017. STYX: a versatile pseudophosphatase.. Biochem Soc Trans 45(2):449-456 PMID: 28408485
  8. 8. David-Pfeuty T et al.. 1990. Serine/threonine-specific protein kinase activity associated with viral pp60src protein.. Eur J Biochem 192(1):55-61 PMID: 2169417
Contact Us
*
*
*
*
How did you hear about us: